| Current News About
what food cause gout :
Kampala — UGANDAN troops entered the Democratic Republic of Congo 20 days ago to flush out the Lord's Resistance Army (LRA) rebels, after its leader, Joseph Kony, refused to sign a peace accord.
As sure as death and taxes, January means resolutions. Dieting always makes the top 10, even this year. The depressing weight-loss business, it seems, remains depression-proof.
US-based Savient Pharmaceuticals has announced that the FDA has accepted for review the companys biologics license application for pegloticase, a biological drug for treatment-failure gout patients.
Kirklander Trevor Hall hasn't looked back since signing up for a 24/7 family doctor access program being offered by a members-only Montreal health-care centre where Quebec medicare cards are not accepted. Hall, 64, said he became a member of Cardiogenix, located on Decarie Boulevard just south of the Metropolitan, about a year ago. ?One of the main reasons I joined was for their complete medical ...
Anyone who's ever had a kidney stone will tell you how painful it can be but some can prevent them.
NEW YORK, NY.- Images by more than forty of the most innovative photographers working in the fashion industry today will be on view in Weird Beauty: Fashion Photography Now, at the International Center of Photography (1133 Avenue of the Americas at 43rd Street) from January 16 through May 3, 2009. To highlight the original context of these photographs, this exhibition will feature hundreds of ...
SURROUNDED by mosques and living with the constant rhythm of Islamic prayer five times a day, Harry Kewell has finally found peace, hope - and goals.
MyFoodMyHealth, Inc. today announced the launch of MyFoodMyHealth , a food and wellness website that provides healthy meal plans, flavorful recipes and online tools designed especially for individuals and families who have multiple health conditions or allergies.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's Biologics License Application (BLA) for pegloticase, a novel biological drug for treatment-failure gout (TFG) patients. The FDA also granted the Company's BLA with a priority review status which accelerates the review period to six months.
|
|
